Načítá se...
Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
BACKGROUND: Immune checkpoint blockade (ICB) is becoming an increasingly prevalent strategy in the clinical realm of cancer therapeutics. With more patients being administered ICB for a host of tumor types, the scope of adverse events associated with these drugs will likely grow. Here we report a ca...
Uloženo v:
| Vydáno v: | Exp Hematol Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859826/ https://ncbi.nlm.nih.gov/pubmed/29568696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-018-0098-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|